8^th Annual Pharma Middle East Congress October 10-12, 2016 Dubai, UAE

Ladislav Novotny was born on October 5, 1955 in Svitavy, Czechoslovakia. He had obtained his Bachelor’s Degree in Pharmaceutical Science from Kharkov Pharmaceutical Institute, Ukraine in 1980; Doctor of Pharmaceutical degree from Charles University in 1981; Doctor of Philosophy degree from Czechoslovak Academy of Sciences in Prague in 1984; Doctor of Science degree from Slovak Academy of Sciences, Bratislava in 1997. He is working as a Professor of Pharmaceutical Chemistry in Kuwait University, since 1998. He is the acting dean of Faculty Pharmacy, since 2003. He is the member of Kuwait Pharmaceutical Association, European Association Cancer Research, American Association Cancer Research, Slovak Pharmacol. Society, Slovak Pharmaceutical Society. He contributed more than 140 articles to reputed Science journals.

Chemotherapy,Anticancer Studies,Cancer Chemotherapy,Cytotoxicity,Apoptosis,Medicinal Chemistry,Analytical Chemistry,Medicinal and Pharmaceutical Chemistry,Elemental Analysis

Dong-Kwon Rhee has completed his PhD at University of Illinois at Chicago in 1988 and Postdoctoral studies from Yale University School of Medicine. He was the Director of World Class University at Sungkyunkwan University, which is ranked 47th in Pharmacy and Pharmacology World rankings 2014. He has published 154 papers in reputed journals and is serving as a President of Korean Society of Ginseng.

Microbial pathogenesis and immunity,Stress response,Vaccine and anti-microbial drugs

Dr. Yousef Alomi, Head of General Administration of Pharmaceutical Care Administration, and Head of National Drug Information Center, MOH Saudi Arabia Dr. Alomi is a product of King Saud University confirmed with the degree of Bachelor of Pharmaceutical Sciences in the year 1992. After six-years of higher study, he earned his Master of Clinical Pharmacy from the same university in the 1998. He is an affiliated clinical instructor of Purdue University in the USA. He is adjunct assistant professor of King Saud University college of Pharmacy. Dr. Alomi was a member of Pharmacy Board at Saudi commission for health Specialties for 1998-2002 and 2008-2012 and Head of Pharmacy Accreditation committee in 2010-2012. He was team member of establishing 1st Pharmacy Residency Program in Saudi Arabia . In the year 2005 he obtained Board Certification of Pharmacotherapy Specialist (BCPS). In the year 2008, he obtained his diploma in business administration from American University in Egypt in 2007, and he obtained a Board Certification of Nutrition Support Pharmacy (BCNSP) in 2009. Dr. Alomi worked as clinical pharmacist in critical care area and nutrition support. He is He is establish and implement several programs at MOH Hospitals at first time; Clinical Pharmacy Program, Medication Safety Program, Pain Management Program, Anticoagulation Program and Pharmacy Infection Control, including 30 Adult and 20 Pediatrics Clinical Pharmacy Program; he founder of Mass Gathering Pharmaceutical Care in Saudi Arabia He became a member of advisory board of the Arab Pharmaceutical Journal in 2010. He became as Pharmacy Board Member of Saudi Commission of Health Care Specialities2010-2013. He had several research in clinical Pharmacy and Pharmacy practice published in ACCP and ISPOR conferences, He had several presentations in the clinical pharmacy and pharmacy practice at several conference in and outside Saudi Arabia.

clinical pharmacy

Randall Bjork is a neurologist from North Dakota who has been in practice for over three decades, mostly in Colorado, emphasizing humane and ethical dementia care. Twenty years ago, he advocated economy-of-scale dementia care with the concept of Lotus Health, which he will present here at our Dubai conference. He was involved in dementia treatment research from the early days of Cognex. He has conducted research with Aricept treatment and MRS evaluation in Down-Alzheimer patients. Dr. Bjork is co-author of a paper being presented here by his Swedish colleague, Dr. Lindau, from The University of Stockholm. He is now involved in a multi-center ketamine treatment protocol of treatment-resistant depression and post-traumatic stress disorder. He has lectured worldwide, contributed to the literature of cardiac arrest, stroke, myoclonus, Alzheimer disease, prionoses and has recently published a children's book, The ABCs of You, Volume I, available on Amazon. He has supervised mission medical work in Costa Rica and Nepal. He is an avid motorcyclist, restaurateur, cancer survivor and retired helicopter pilot.

Neurodegenerative diseases,Neuropharmacology.

Maria Lindau, Licensed Psychologist and PhD, is associate professor at the Dept. of Psychology, Stockholm University, Sweden. She has about 20 publications, and 15 years of experience as neuropsychologist and researcher at memory clinics at Karolinska and Uppsala university hospitals. She is Bachelor of Arts in History, French and Political Science.

Neuropsychology

David W. Moskowitz is a well-trained nephrologist and founder, CEO, and Chief Medical Officer of GenoMed, a next Generation DM(tm) company (DM = Disease Management).

Genomics, disease pathways, clinical research, medical practice, diagnostics, drug discovery, disease management

Ashraf Allam is the Regional Vice President for Mundipharma Middle East and Africa region, based in Dubai. Mundipharma is a leading research and manufacturing privately held US Pharmaceutical company with annual revenues around $5.0 Billions In this role, Ashraf manages Mundipharma business in the MEA countries and is fully accountable for the profit and loss. Over the last five years, Ashraf has served as the elected Chairman, Executive Committee for the association of American, European and Japanese research based manufacturing pharmaceutical and biotechnology companies (PhRMA) in the Middle East and Africa. Prior to joining Mundipharma in late 2013, Ashraf has worked for Amgen; the world's largest Biopharmaceuticals Company at their international headquarter in Switzerland, where he served as the vice president for international business development in addition to being in charge of the European markets of Italy, Greece and the Balkans. He was charged with exploiting all potential opportunities to grow, diversify and globalize Amgen's business, and was a key executive in the global strategy and commercial development team. Ashraf then moved to Dubai in 2006 to start up Amgen's operation in the Middle East, Africa and Turkey region and built it to become now among the top leading companies in the region. From 2001 to 2004 Ashraf served at Johnson & Johnson as the Managing Director, in charge of managing and leading the group’s umbrella of diversified companies based in Cairo. Prior to that, he worked for Eli Lilly & company in a variety of general management, sales, marketing, management development and business development roles in the US, Europe and the Middle East. Latterly he was the Director of Global economic affairs and pricing based in Indiana, USA, having previously been based in Geneva, Switzerland as head of area sales and marketing operations for central Eastern Europe and Middle East, Africa

Business Development, Management, Business Strategy, Pharmaceutical Industry, Sales, Marketing

Pierre Lutgen is the founder of NGO, IFBV-BELHERB in Luxembourg. Since 5 years the NGO IFBV from Luxembourg has established a working relationship with African universities, in close cooperation with other European research institutions.

clinical trials, antimalarial activity

Sergio Steffenoni is the Managing Director of SLB Engineering GmbH at Germany. After having worked for the Pharma industry for almost 20 years in Engineering roles of increasing complexity and responsibility, he has now founded his own company to provide Consulting and Value Engineering Services to Pharma and Biotech companies.SLB Engineering GmbH offers extensive experience in the Pharma industry and effective project management, joined by an integrated approach focused on delivering solutions which match the triangle Quality, Time and Cost.

Technical Feasibility and Infrastructure Studies, Concept Design, Basic and Detailed Engineering of Pharma/Biotech Plants, GMP/GEP/GLP Consulting, Revamping and new Pharmaceuticals manufacturing Plants, Qualification and Validation Services, Commissioning Support, Procurement Support

Don Skerrett is a seasoned business leader with a visionary, entrepreneurial spirit. He’s passionate about growing and improving businesses and the people who run them. Don has a strong track record of building successful relationships and has helped more than 100 startups get to the next level.Don also serves as Chairman and Chief Executive Officer of NanoScan Imaging, an early-stage diagnostics company whose lead technology gives physicians a new way to image cardiovascular disease and metastatic cancers. As PCCI's Chairman and President, Don built up the Pharmaceutical Consulting Consortium International from 10 to 400 members. PCCI has mentored over 100 life science start-ups over the past 10 years. Don’s career spans pharmaceutical advertising, media promotion, magazine publishing, consumer advertising, market research, management consulting and corporate acquisitions. He has founded and run several early-stage companies, including BreakAway Sports, Sportsworks Interactive and the Interactive Advertising Council in Washington, DC.

pharmaceutical advertising, media promotion, magazine publishing, consumer advertising, market research, management consulting

Saeed Qureshi is the Principal at PharmacoMechanics, Canada. He has an extensive experience of 30 years in conducting hands-on and multi-disciplinary laboratory research in pharmaceutical areas in a regulatory environment with Health Canada. He has thorough knowledge and understanding of various concepts (e.g. SUPAC, BCS, IVIVC, QbD) and standards and guidelines (e.g. FDA, USP, ICH) pertaining to developing and setting standards for establishing quality, safety and efficacy of pharmaceuticals. His publications include book chapters; numerous national and international presentations and course teaching assignments. He is the recipient of Health Canada’s Deputy Minister Award for Excellence in Science and Editor-in-Chief of The Open Drug Delivery Journal.

Pharmacokinetics, biopharmaceutics, drug dissolution testing, analytical chemistry as related to characterization of pharmaceuticals, in particular based on in vitro (dissolution) and bioavailability/bioequivalence (humans and animals) assessments.